Changed terms for drug payment influenced GPs’ diagnoses and prescribing practice for inhaled corticosteroids

BACKGROUND: Inhaled glucocorticosteroids (ICS) are first-line anti-inflammatory treatment in asthma, but not in chronic obstructive pulmonary disease (COPD). To restrict ICS use in COPD to cases of severe disease, new terms for reimbursement of drug costs were introduced in Norway in 2006, requiring...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalbak, Lene G., Rognstad, Sture, Melbye, Hasse, Straand, Jørund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696339/
https://www.ncbi.nlm.nih.gov/pubmed/23560809
http://dx.doi.org/10.3109/13814788.2013.766713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696339/
https://www.ncbi.nlm.nih.gov/pubmed/23560809
http://dx.doi.org/10.3109/13814788.2013.766713

Ejemplares similares